Lalit Kumar

Director - Clinical Bioanalytics & Translational Science Beam Therapeutics

Seminars

Thursday 30th July 2026
Exploring a Translational Biomarker Framework for Cell & Gene Therapies
11:30 am
  • Showcasing the rationale behind selecting biomarkers to answer modality‑specific questions for cell and gene therapies
  • Highlighting how PDX models are used to back‑translate clinical observations
  • Demonstrating how validated assay outputs directly inform clinical strategy, strengthening patient‑selection, response‑stratification and biomarker frameworks for early‑phase trials
Lalit Kumar- 14th Tumor Models Boston Summit 2026